This is a Vertex news story, published by Yahoo Finance, that relates primarily to Casgevy news.
For more Vertex news, you can click here:
more Vertex newsFor more Casgevy news, you can click here:
more Casgevy newsFor more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
big biotech stocks. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest largest healthcare stock news, growth stocks news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
healthcare stockThe Motley Fool
•69% Informative
Three Motley Fool contributors believe they've identified good biotech stocks.
They say Eli Lilly , Novo Nordisk and Vertex Pharmaceuticals are growth stocks you can buy right now.
The first trillion-dollar healthcare stock? Eli Lilly is definitely a no-brainer growth stock, even considering its shares have soundly outperformed the market.
Vertex Pharmaceuticals recently submitted regulatory filings in the U.S. and Europe for its vanzacaftor triple-drug combo.
Casgevy , the first CRISPR gene-editing therapy ever, is widely expected to be another blockbuster drug for Vertex .
In April , Vertex announced plans to acquire Alpine Immune Sciences for $4.9 billion .
VR Score
62
Informative language
61
Neutral language
41
Article tone
formal
Language
English
Language complexity
48
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
9
Source diversity
2
Affiliate links
no affiliate links